8 pending office actions • 2 clients
| Client (Assignee) | Pending OAs |
|---|---|
| Regeneron Pharmaceuticals, Inc. | 4 |
| Regeneron Pharmaceuticals, Inc. | 4 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 18680910 | ANTI-NPR1 ANTIBODIES AND USES THEREOF | Regeneron Pharmaceuticals, Inc. | HOWARD, ZACHARY C | 1674 | Non-Final OA | May 31, 2024 |
| 18584551 | ANTI-ACVR1 ANTIBODIES AND USES THEREOF | Regeneron Pharmaceuticals, Inc. | DEBERRY, REGINA M | 1647 | Non-Final OA | Feb 22, 2024 |
| 18495477 | ANTI-ACVRI ANTIBODIES AND THEIR USE IN THE TREATMENT OF TRAUMA-INDUCED HETEROTOPIC OSSIFICATION | Regeneron Pharmaceuticals, Inc. | MELCHIOR, JAMES RYLAND | 1644 | Non-Final OA | Oct 26, 2023 |
| 18482448 | ANTI-PTCRA ANTIBODY-DRUG CONJUGATES AND USES THEREOF | Regeneron Pharmaceuticals, Inc. | HUYNH, PHUONG N | 1641 | Non-Final OA | Oct 06, 2023 |
| 18472160 | METHODS OF TREATING OBESITY, DIABETES, AND LIVER DYSFUNCTION | Regeneron Pharmaceuticals, Inc. | PRIEST, JESSICA MARIE | 1642 | Non-Final OA | Sep 21, 2023 |
| 18462320 | METHOD OF TREATING AN ALLERGY WITH ALLERGEN-SPECIFIC MONOCLONAL ANTIBODIES | Regeneron Pharmaceuticals, Inc. | TAYLOR, LIA ELAN | 1641 | Non-Final OA | Sep 06, 2023 |
| 18059315 | ANTI-ACTIVIN A ANTIBODIES AND USES THEREOF | Regeneron Pharmaceuticals, Inc. | MCCOLLUM, ANDREA K | 1674 | Non-Final OA | Nov 28, 2022 |
| 18045588 | ANTIBODIES TO HUMAN GDF8 | Regeneron Pharmaceuticals, Inc. | XIE, XIAOZHEN | 1674 | Final Rejection | Oct 11, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial